Bruker Corporation - Common Stock (NQ:BRKR)

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

3 Cash-Producing Stocks We Steer Clear Of

October 07, 2026

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

Performance

52-Week Range 18.2% below 52-week high

54.80

32.3752W Low 66.9852W High

1 Week 6.7% below 1-week high

54.271W Low 58.751W High

Bruker Corporation - Common Stock (BRKR) traded between $32.37 and $66.98 over the past 52 weeks and last traded at $54.80, 18.2% below its 52-week high. Over the past week it ranged between $54.27 and $58.75.

Past 12 Months

-2.6%

-9.7%

-5.9%

+34.6%

+13.9%

+43.5%

1W -$1.45

1M -$5.87

3M -$3.43

6M +$14.10

YTD +$6.69

1Y +$16.60

BRKR was +43.5% over the past year, +34.6% over six months, +13.9% year to date, -2.6% in the last week.

12 Months vs Market

BRKR

+43.5%

DIA

+13.0%

SPY

+15.5%

QQQ

+18.3%

IWM

+10.4%

Over the past 12 months BRKR returned +43.5% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.74× 3-mo avg

Today 1,674,222 3-mo avg 2.3M

2.0M

2.4M

2.3M

2.4M

YTD

2.4M

BRKR most recently traded 1,674,222 shares against a 3-month average daily volume of 2.3M.

More News

October 06, 2026

1 Surging Stock to Target This Week and 2 We Question

October 05, 2026

Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

September 28, 2026

Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound ↗

September 26, 2026

Via MarketBeat

September 21, 2026

Why Bruker (BRKR) Stock Is Falling Today

September 09, 2026

Bruker Corporation to Present at Upcoming Investor Conferences

September 08, 2026

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

September 04, 2026

3 Small-Cap Stocks We’re Skeptical Of

September 02, 2026

Research Tools & Consumables Stocks Q2 Highlights: Bruker (NASDAQ:BRKR)

August 31, 2026

August 21, 2026

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker (BRKR) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Via The Motley Fool

August 11, 2026

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

August 11, 2026

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

August 10, 2026

BRKR Q2 Deep Dive: Margin Expansion and Delayed Revenue Impact Market Sentiment

August 05, 2026

Bruker (BRKR) Stock Trades Down, Here Is Why

August 04, 2026

Bruker (NASDAQ:BRKR) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.9%

Bruker Q2 Earnings Call Highlights ↗

August 04, 2026

Via MarketBeat

August 04, 2026

Bruker Reports Second Quarter 2026 Financial Results

August 04, 2026

Earnings To Watch: Bruker (BRKR) Reports Q2 Results Tomorrow

August 02, 2026

3 Reasons to Sell BRKR and 1 Stock to Buy Instead

July 27, 2026

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

July 24, 2026